SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-002241
Filing Date
2024-03-01
Accepted
2024-03-01 09:16:05
Documents
50
Period of Report
2024-03-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K glyc-20240301x8k.htm   iXBRL 8-K 41763
2 EX-99.1 glyc-20240301xex99d1.htm EX-99.1 53512
3 GRAPHIC glyc-20240301xex99d1g001.jpg GRAPHIC 203135
4 GRAPHIC glyc-20240301xex99d1g002.jpg GRAPHIC 207432
5 GRAPHIC glyc-20240301xex99d1g003.jpg GRAPHIC 159781
6 GRAPHIC glyc-20240301xex99d1g004.jpg GRAPHIC 142330
7 GRAPHIC glyc-20240301xex99d1g005.jpg GRAPHIC 153668
8 GRAPHIC glyc-20240301xex99d1g006.jpg GRAPHIC 103488
9 GRAPHIC glyc-20240301xex99d1g007.jpg GRAPHIC 183222
10 GRAPHIC glyc-20240301xex99d1g008.jpg GRAPHIC 151908
11 GRAPHIC glyc-20240301xex99d1g009.jpg GRAPHIC 149832
12 GRAPHIC glyc-20240301xex99d1g010.jpg GRAPHIC 137255
13 GRAPHIC glyc-20240301xex99d1g011.jpg GRAPHIC 145430
14 GRAPHIC glyc-20240301xex99d1g012.jpg GRAPHIC 145900
15 GRAPHIC glyc-20240301xex99d1g013.jpg GRAPHIC 144851
16 GRAPHIC glyc-20240301xex99d1g014.jpg GRAPHIC 150000
17 GRAPHIC glyc-20240301xex99d1g015.jpg GRAPHIC 158617
18 GRAPHIC glyc-20240301xex99d1g016.jpg GRAPHIC 117301
19 GRAPHIC glyc-20240301xex99d1g017.jpg GRAPHIC 148141
20 GRAPHIC glyc-20240301xex99d1g018.jpg GRAPHIC 139356
21 GRAPHIC glyc-20240301xex99d1g019.jpg GRAPHIC 152672
22 GRAPHIC glyc-20240301xex99d1g020.jpg GRAPHIC 149337
23 GRAPHIC glyc-20240301xex99d1g021.jpg GRAPHIC 121031
24 GRAPHIC glyc-20240301xex99d1g022.jpg GRAPHIC 145524
25 GRAPHIC glyc-20240301xex99d1g023.jpg GRAPHIC 147297
26 GRAPHIC glyc-20240301xex99d1g024.jpg GRAPHIC 213135
27 GRAPHIC glyc-20240301xex99d1g025.jpg GRAPHIC 179479
28 GRAPHIC glyc-20240301xex99d1g026.jpg GRAPHIC 203516
29 GRAPHIC glyc-20240301xex99d1g027.jpg GRAPHIC 184681
30 GRAPHIC glyc-20240301xex99d1g028.jpg GRAPHIC 167468
31 GRAPHIC glyc-20240301xex99d1g029.jpg GRAPHIC 171394
32 GRAPHIC glyc-20240301xex99d1g030.jpg GRAPHIC 179683
33 GRAPHIC glyc-20240301xex99d1g031.jpg GRAPHIC 123688
34 GRAPHIC glyc-20240301xex99d1g032.jpg GRAPHIC 119135
35 GRAPHIC glyc-20240301xex99d1g033.jpg GRAPHIC 159864
36 GRAPHIC glyc-20240301xex99d1g034.jpg GRAPHIC 125546
  Complete submission text file 0001558370-24-002241.txt   7605692

Data Files

Seq Description Document Type Size
37 EX-101.SCH glyc-20240301.xsd EX-101.SCH 3800
38 EX-101.LAB glyc-20240301_lab.xml EX-101.LAB 1355
39 EX-101.PRE glyc-20240301_pre.xml EX-101.PRE 10724
51 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20240301x8k_htm.xml XML 4612
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 24707236
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)